Browse Related Topics For:

Pharmaceutical Industry

1104
Prescription Drugs
1043
FDA
1018
Patents
759
Pharmaceutical Patents
636
Patent Litigation
551
Generic Drugs
503
Patent Infringement
436
Biosimilars
424
Medical Devices
314
ANDA
300
Healthcare
241
SCOTUS
230
Biotechnology
217
Hatch-Waxman
210
Manufacturers
196
BPCIA
186
Popular
184
Drug Pricing
179
Biologics
172
Health Care Providers
172
Life Sciences
159
EU
159
FTC
155
Off-Label Promotion
151
CMS
149
HHS
147
Pharmacies
143
Medicare
140
Physicians
135
Affordable Care Act
126
China
124
Amgen
124
Medicaid
121
Clinical Trials
120
DOJ
118
Sandoz
116
False Claims Act (FCA)
116
Teva Pharmaceuticals
115
Section 340B
113
FDA Approval
112
FDCA
112
Hospitals
104
Mylan Pharmaceuticals
102
First Amendment
99
Sandoz v Amgen
97
Patent-in-Suit
96
Enforcement Actions
96
Preemption
95
Patent Trial and Appeal Board
92
Inter Partes Review (IPR) Proceeding
92
Off-Label Use
92
SEC
91
Compliance
88
Class Action
88
Intellectual Property Protection
87
Appeals
84
HRSA
81
Claim Construction
78
Actavis Inc.
78
Labeling
77
Pfizer
73
Novartis
73
OIG
73
UK
73
USPTO
72
Failure To Warn
72
FCPA
71
Marketing
70
Antitrust Litigation
70
Obviousness
69
Corporate Counsel
68
Pay-For-Delay
68
Reverse Payment Settlement Agreements
64
Draft Guidance
64
GlaxoSmithKline
64
Patent-Eligible Subject Matter
64
Trump Administration
62
FTC v Actavis
61
Sunshine Act
59
Australia
57
Anti-Kickback Statute
57
Bribery
57
Patent Dance
57
Personal Jurisdiction
56
Apotex
56
Orphan Drugs
56
Teva v Sandoz
55
Settlement
54
Preliminary Injunctions
53
Medical Research
52
Health Insurance
52
Prior Art
52
Warning Labels
52
Whistleblowers
51
Comment Period
50
Advertising
50
Civil Monetary Penalty
50
De Novo Standard of Review
50
Infringement
50
Opioid
50
Reporting Requirements
49
Amarin
49
AstraZeneca
49
Free Speech
49
Patent Applications
48
Clear Error Standard
48
Federal Rules of Civil Procedure
47
Commercial Marketing
47
Medicare Part D
45
AbbVie
45
European Medicines Agency (EMA)
45
Fraud
45
PHRMA
45
Research and Development
44
Disclosure Requirements
44
Merck
43
21st Century Cures Initiative
42
Criminal Prosecution
42
Financial Sector
41
Misbranding
41
Multidistrict Litigation
40
Bayer
40
Covered Entities
40
Pending Legislation
39
Legislative Agendas
39
Mergers
39
Negligence
39
Patent Invalidity
39
Proposed Legislation
39
Regulatory Standards
38
America Invents Act
38
Canada
38
Hospira
38
Summary Judgment
37
Acquisitions
37
Competition
37
Eli Lilly
37
Notice Requirements
36
Final Rules
36
Product Defects
35
Design Defects
35
Drug Safety
35
Hart-Scott-Rodino Act
35
Healthcare Reform
35
Public Health
35
White Collar Crimes
34
Antitrust Provisions
34
Declaratory Judgments
34
Johnson & Johnson
34
Sherman Act
33
Dismissals
33
HIPAA
33
Qui Tam
33
Regulatory Oversight
32
Drug Compounding
32
Kickbacks
32
Trademarks
31
Cancer
31
Drug & Alcohol Abuse
30
Anti-Corruption
30
Bristol-Myers Squibb
30
Causation
30
Commercial Speech
30
Healthcare Facilities
30
Janssen Pharmaceuticals
30
Transparency
29
Allergan Inc
29
Enforcement
29
European Commission
29
Innovation
29
Product Labels
29
Proposed Regulation
29
Safe Harbors
28
Abbott Laboratories
28
Anti-Competitive
28
Antitrust Violations
28
DNA
28
EPA
28
False Advertising
28
Gilead Sciences
28
Insurance Industry
28
Jurisdiction
28
Watson Pharmaceuticals
27
Learned Intermediary
27
Mass Tort Litigation
27
New Guidance
27
NIH
27
Securities Fraud
26
Expert Testimony
26
GPOs
26
Healthcare Fraud
26
Motion to Dismiss
25
aBLA
25
Corruption
25
Cybersecurity
25
Discovery
25
Financial Markets
25
Imports
25
Medicare Part B
25
New Legislation
25
UK Brexit
24
DaimlerChrysler v Bauman
24
General Jurisdiction
24
Mental Health
24
Specific Jurisdiction
24
Standing
23
Biologics Price Competition and Innovation Act of 2009
23
Product Hopping
23
Public Comment
23
Valeant
22
Birth Defects
22
Hazardous Waste
22
Insider Trading
22
Misrepresentation
22
PLIVA v Mensing
22
Scientific Research
21
Celltrion
21
Class Certification
21
Disgorgement
21
Ethics
21
FFDCA
21
Genentech
21
Strict Liability
21
Substance Abuse
21
Trans-Pacific Partnership
20
France
20
India
20
Patients
20
Pleading Standards
20
Takeda Pharmaceuticals
20
Technology Sector
20
Wrongful Death
19
Attorney Generals
19
Banking Sector
19
Biopharmaceutical
19
Citizen Petitions
19
Damages
19
DEA
19
Hedge Funds
19
Licenses
19
Patent Reform
19
Russia
19
Social Media
19
Supply Chain
18
Audits
18
Caronia
18
Chief Compliance Officers
18
DSCSA
18
Duty to Warn
18
Lanham Act
18
Mutual Pharmaceuticals v Bartlett
18
On-Sale Bar
18
Orange Book
18
Professional Conferences
18
Public Health Service Act
18
Securities Litigation
18
Trade Secrets
17
Antitrust Investigations
17
Bristol-Myers Squibb Co v Superior Court of California - San Francisco County
17
Congressional Investigations & Hearings
17
Evidence
17
Forum Shopping
17
Medical Malpractice
17
Prescription Drug Coverage
17
Product Exclusivity
17
RCRA
17
Regulatory Agenda
17
Side Effects
16
Barack Obama
16
Drug Approvals
16
Exports
16
Federal Contractors
16
Innovator Liability
16
License Agreements
16
Monopolization
16
Myriad
16
Omnicare
16
Penalties
16
Post-Grant Review
16
Price-Fixing
16
Putative Class Actions
16
Stocks
16
Technology
16
Unfair Competition
16
Warner Chilcott
16
Warning Letters
16
Yates Memorandum
15
AMP v Myriad
15
Automotive Industry
15
CA Supreme Court
15
Cartels
15
Cephalon
15
Certiorari
15
Coherus
15
Controlled Substances
15
Data Protection
15
Distributors
15
Final Guidance
15
Intellectual Property Litigation
15
Joint Venture
15
Mayo v. Prometheus
15
Open Payments
15
Par Pharmaceutical
15
Personalized Medicine
15
Private Equity
15
Reimbursements
15
Wells Fargo
15
World Health Organization
14
21st Century Cures Act
14
Administrative Procedure Act
14
GAO
14
Genetic Materials
14
Government Investigations
14
Japan
14
OMB
14
Pregnancy
14
Relators
14
REMS
14
Repeal
14
Securities
14
Settlement Agreements
14
Telemedicine
14
Trade Agreements
14
UK Competition and Markets Authority (CMA)
14
Venture Capital
14
Wyeth
13
CAFA
13
Copyright
13
Drug Distribution
13
Endo Pharmaceuticals
13
Energy Sector
13
Fee-for-Service
13
Inadequate Warning
13
Induced Infringement
13
Interchangeability
13
Investigational New Drug Application (IND)
13
IP License
13
Italy
13
Martin Shkreli
13
Medicare Advantage
13
Pain Management
13
Physician Medicare Reimbursements
13
Professional Misconduct
13
Rebates
13
Risk Assessment
13
Risk Management
13
Theranos
13
Universal Health Services Inc v United States ex rel Escobar
13
Wholesale
12
Banks
12
Boehringer
12
Breach of Contract
12
CHIP
12
Competition Authorities
12
Confidential Information
12
Diagnostic Tests
12
DQSA
12
Foreign Investment
12
Injunctive Relief
12
IPO
12
Medtronic
12
Oil & Gas
12
Omnicare v Laborers District Council
12
PHI
12
Product Recalls
12
Publicly-Traded Companies
12
RICO
12
Sanofi-Aventis
12
Section 11
12
Social Networks
12
Stark Law
12
Startups
12
Teaching Hospitals
12
Ukraine
11
3D Printing
11
Breach of Warranty
11
Chemicals
11
Co-payments
11
Data Collection
11
Dietary Supplements
11
DOL
11
Exclusivity
11
Expert Witness
11
Financial Conduct Authority (FCA)
11
Foreign Corporations
11
Fraudulent Joinder
11
Generic
11
Genzyme
11
Health Information Technologies
11
Human Genes
11
Injunctions
11
Investors
11
Manufacturing Defects
11
Material Misstatements
11
MCOs
11
Mexico
11
Misleading Statements
11
Nexium
11
OFAC
11
Otsuka Pharmaceutical
11
Patent Term Extensions
11
Payment Records
11
Petition for Writ of Certiorari
11
Presidential Elections
11
Public Disclosure
11
Public Meetings
11
Retailers
11
Sanctions
11
Securities Act of 1933
11
Software
11
Subject Matter Jurisdiction
11
Young Lawyers
10
Adverse Events
10
Brazil
10
CDC
10
Clinical Laboratories
10
CLS Bank v Alice Corp
10
Corporate Culture
10
Data Breach
10
Department of Health
10
Due Process
10
Durable Medical Equipment
10
En Banc Review
10
Federal Budget
10
Financial Institutions
10
Genetic Testing
10
Google
10
Hackers
10
Informed Consent
10
Long Term Care Facilities
10
Managed Care Contracts
10
Materiality
10
Medical Supplies
10
Merger Agreements
10
Ministry of Health
10
New Regulations
10
Nurses
10
Omnibus Guidance
10
OxyContin
10
Patent Term Adjustment
10
Physician Payments
10
Registration Requirement
10
Remand
10
RMBS
10
Securities Exchange Act
10
Tax Credits
10
Telecommunications
10
Unfair or Deceptive Trade Practices
10
User Fees
10
Vaccinations
10
Zoloft
9
ACOs
9
Amgen v Sandoz
9
Antitrust Division
9
Arbitration
9
Brand
9
CFDA
9
China FDA
9
Conflicts of Interest
9
Continuing Medical Education
9
Controlled Substances Act
9
Cross-Border Transactions
9
Defense Strategies
9
EEA
9
Export Controls
9
Federal Funding
9
Fiduciary Duty
9
Fiduciary Rule
9
Food Manufacturers
9
Germany
9
Good Faith
9
Healthcare Costs
9
Illegal Drugs
9
Legislative Committees
9
Marketing Authorization Application
9
Medicaid Expansion
9
Member State
9
Negligent Misrepresentation
9
Nursing Homes
9
Private Right of Action
9
Punitive Damages
9
RanBaxy
9
Registration Statement
9
Reverse Payments
9
Roxane Laboratories
9
Rule-of-Reason Analysis
9
Rulemaking Process
9
Sanofi
9
Shareholder Litigation
9
Standard of Review
9
Statute of Limitations
9
Strategic Enforcement Plan
9
Value-Based Purchasing
9
Websites
8
Anti-Monopoly
8
Aviation Industry
8
Biogen Idec
8
BRCA
8
Corporate Integrity Agreement
8
Deferred Prosecution Agreements
8
Due Diligence
8
Employee Benefits
8
Environmental Policies
8
Fines
8
FINRA
8
First-to-File
8
FOIA
8
Fourteenth Amendment
8
Fraud and Abuse
8
Guidance Update
8
Hiring & Firing
8
Interpretive Rule
8
Inventions
8
Inventors
8
Ireland
8
IRS
8
Joinder
8
Jury Verdicts
8
MedPAC
8
Mensing
8
Multinationals
8
Noninfringement
8
Obama Administration
8
OCR
8
Patient Assistance Programs
8
Permanent Injunctions
8
PHSA
8
Public Hearing
8
Public Offerings
8
Recordkeeping Requirements
8
Royalties
8
Safe Drug Disposal
8
Scienter
8
Section 101
8
Securities Violations
8
Shareholders
8
USDA
8
Wage and Hour
8
Written Descriptions
8
WTO
7
Administrative Proceedings
7
Africa
7
Agricultural Sector
7
AIDS
7
Allergan v Sandoz
7
Auto Manufacturers
7
Bank Accounts
7
Black Box Warnings
7
Bonds
7
Burden of Proof
7
C-Suite Executives
7
Capital Raising
7
Cost-Sharing
7
Databases
7
Daubert Standards
7
Diagnostic Method
7
Economic Development
7
Facebook
7
False Statements
7
Federal Pilot Programs
7
Federal Rule 12(b)(6)
7
Food Labeling
7
Forest Laboratories
7
Funding
7
Home Health Care
7
Hospital Mergers
7
Indictments
7
Innovation Act
7
Internal Controls
7
International Harmonization
7
Inversion
7
Investment
7
Jazz Pharmaceuticals
7
License Applications
7
Licensing Rules
7
Limelight v Akamai
7
Meals-Gifts-and Entertainment Rules
7
Medical Marijuana
7
Monsanto
7
Myriad-Mayo
7
Negotiations
7
New Zealand
7
OECD
7
OPDP
7
Pleadings
7
Premerger Notifications
7
Price Gouging
7
Radiopharmaceuticals
7
Referendums
7
Regulatory Agencies
7
Samsung
7
Samsung Bioepis
7
Skilled Nursing Facility
7
State and Local Government
7
Subpoenas
7
Tariffs
7
The Clayton Act
7
Third-Party
7
Trademark Infringement
7
TRIPS Agreement
7
Twombly/Iqbal Pleading Standard
7
Vacated
7
Walgreens
7
Yahoo!
6
Anti-Bribery
6
Applications
6
Attorney-Client Privilege
6
Australian Patent Office
6
Bayh-Dole Act
6
Big Data
6
BIS
6
CETA
6
CGMP
6
Choice-of-Law
6
Commercial Bankruptcy
6
Compensatory Damages
6
Conspiracies
6
Consumer Fraud
6
Corporate Misconduct
6
Corporate Taxes
6
Cosmetics
6
Covered Recipients
6
Criminal Conspiracy
6
Cross-Border
6
Cross-Selling
6
Cyber Attacks
6
Data Security
6
Data-Sharing
6
Daubert Ruling
6
Declaratory Relief
6
Digital Health
6
Disclosure
6
Discount Pricing
6
Diversity Jurisdiction
6
Dodd-Frank
6
E-Commerce
6
Emerging Growth Companies
6
Exclusive Dealing Agreements
6
Executive Orders
6
False Implied Certification Theory
6
FCC
6
Federal Jurisdiction
6
Federal Register
6
Food and Drug Administration Amendments Act (FDAAA)
6
Foreign Official
6
Forum
6
FTC Act
6
General Motors
6
Guilty Pleas
6
Health Insurance Exchanges
6
Hoffman LaRoche
6
Initial Public Offerings
6
Inspections
6
Interest Rate Adjustments
6
Internet
6
Iran
6
ITC
6
JPMorgan Chase
6
Lipitor
6
Medicaid Reimbursements
6
Merger Controls
6
Method Claims
6
Mobile Apps
6
Mortgages
6
NAFTA
6
Online Advertisements
6
Outsourcing
6
Patent Prosecution
6
Patent Trolls
6
Patient Privacy Rights
6
PDUFA
6
Pharmaceutical Reverse Distributors
6
Pharmacist
6
Provider Payments
6
Public Health Insurance Marketplace
6
Public Safety
6
Real Party in Interest
6
Regulatory Reform
6
Reversal
6
Risk Mitigation
6
Secretary of HHS
6
Section 337
6
SFDA
6
Shire Development v Watson
6
Small Business
6
South Korea
6
Standard Essential Patents
6
State of Incorporation
6
Statement of Opinion
6
Suppliers
6
TCPA
6
Telehealth
6
Toxic Exposure
6
Transportation Industry
5
510(k) RTA
5
Abuse of Dominance
5
Abuse of Process
5
Admissible Evidence
5
ALJ
5
American Medical Association
5
Amicus Briefs
5
Anticompetitive Behavior
5
Article III
5
Asia
5
Australian Competition and Consumer Commission
5
Bodily Injury
5
CAFC
5
Celebrity Endorsements
5
CEOs
5
Chevron Deference
5
Cipro
5
Classen Immunotherapies
5
Competition Act
5
Compulsory Licenses
5
Construction Industry
5
Consumer Lenders
5
CVS
5
Department of Veterans Affairs
5
Deutsche Bank
5
Direct Infringement
5
Dispute Resolution
5
Divided Infringement
5
Domestic Violence
5
Dormant Commerce Clause
5
Elder Abuse
5
Employer Group Health Plans
5
Enablement Inquiries
5
FBI
5
FD&C Act
5
FDA Warning Letters
5
Federal Reserve
5
Fifth Amendment
5
Food Safety
5
Foreign Manufacturers
5
Forum Selection
5
Fresenius
5
General Electric
5
Goldman Sachs
5
Good Clinical Practices
5
Hazardous Substances
5
HCEI
5
HITECH
5
HIV
5
Hospice
5
Interest Rates
5
International Arbitration
5
JAMA
5
Jury Instructions
5
Kaiser Permanente
5
Likelihood of Confusion
5
Litigation Strategies
5
Medical Reimbursement
5
Medicines and Healthcare Products Regulatory Agency (MHRA)
5
Mootness
5
Motion for Summary Judgment
5
Motion To Stay
5
No-AG Agreement
5
Online Marketplace Lending
5
Over-the-Counter Sales
5
Overpayment
5
PATENT Act
5
Patient Safety
5
Personal Care Products
5
Physician Gift-Ban Law
5
Pre-Merger Filing Requirements
5
Privacy Laws
5
Proposed Amendments
5
Proximate Cause
5
PSLRA
5
Remedies
5
Removal
5
Retaliation
5
Retirement Plan
5
Section 10(b)
5
Sharing Economy
5
Software Developers
5
Solicitor General
5
Solid Waste
5
South Africa
5
Spain
5
Stem cells
5
Subsidies
5
Surveys
5
Tax Reform
5
The Common Rule
5
Trade Agreements Act
5
Trade Relations
5
Trademark Registration
5
Trademark Trial and Appeal Board
5
Training
5
Twitter
5
UK Bribery Act
5
Unions
5
USTR
5
Vendors
5
Verification Requirements
5
Veterinary Products
5
Volkswagen
5
Waivers
4
23andMe
4
Acquittals
4
Actos
4
Administrative Authority
4
Advisory Committee
4
Aerospace
4
Alzheimer's
4
Amended Legislation
4
Amgen v Hospira
4
Anti-SLAPP
4
Antibiotics
4
Antitrust Conspiracies
4
Antitrust Injuries
4
Apple
4
Applicable Manufacturers
4
Ascertainable Class
4
Attorney's Fees
4
Aurobindo Pharmaceuticals
4
Australian Medical Association
4
Ballot Measures
4
Barclays
4
Best Practices
4
Board of Directors
4
Breach of Duty
4
Calculation of Damages
4
Cardinal Health
4
Climate Change
4
CMMI
4
Code of Conduct
4
Confidentiality Agreements
4
Consent Order
4
Contraceptives
4
Cooperation
4
Counterclaims
4
Counterfeit Drugs
4
Criminal Investigations
4
Cuba
4
Daiichi Sankyo
4
Dairy Farmers
4
Data Privacy
4
Department of Transportation (DOT)
4
Deregulation
4
Derivative Suit
4
Digital Currency
4
Divestiture
4
DMEPOS
4
Doctrine of Equivalents
4
Double Patent
4
Duty of Care
4
Duty to Deal
4
EAR
4
Economic Sanctions
4
EHR
4
Elan Pharmaceuticals
4
Employment Contract
4
ERISA
4
EU Single Market
4
EU-US Privacy Shield
4
European Court of Justice (ECJ)
4
Excessive Pricing
4
Exemptions
4
Failure To Disclose
4
Failure To State A Claim
4
Fair Work Commission
4
FDASIA
4
Food Recalls
4
Forum Non Conveniens
4
FRAND
4
French Competition Authority
4
GDUFA
4
Genetic Markers
4
Global Marketplace
4
Health Canada
4
Hepatitis C
4
Human Rights
4
Implied Preemption
4
Individual Accountability
4
Information Technology
4
Interlocutory Injunctions
4
InterMune
4
Interstate Commerce
4
Investment Adviser
4
Investment Management
4
IRB
4
Job Creation
4
Kim Kardashian
4
Kimble v Marvel Enterprises
4
Laboratory Developed Tests
4
Libor
4
Local Ordinance
4
Marijuana
4
Material Nonpublic Information
4
Medical Records
4
Medicare Access and CHIP Reauthorization (MACRA)
4
Microsoft
4
Middle East
4
Minimum Contacts
4
Mining
4
Misleading Impressions
4
MOFCOM
4
Morgan Stanley
4
Motion To Strike
4
Nanotechnology
4
National Cancer Moonshot
4
NDRC
4
Non-Prosecution Agreements
4
Nutritional Supplements
4
OTC
4
Pain Management Clinics
4
Partnerships
4
Patent Portfolios
4
Pediatrics
4
Pension Funds
4
Pensions
4
Personal Liability
4
Pharmaceutical Distribution
4
Physician Fee Schedule
4
PMNOC Regulations
4
Policies and Procedures
4
Prejudgment Interest
4
Premiums
4
Prior Express Consent
4
Public Officials
4
Quality Control Plan
4
Red Notices
4
Regeneron
4
Retail Market
4
Rule 9(b)
4
Safety Standards
4
Schering-Plough
4
SDN List
4
Sealed Records
4
Section 2
4
Shareholder Activism
4
Shipping
4
SmithKline Beecham
4
Social Services
4
STRONG Patents Act
4
Stryker
4
Supplementary Protection Certificate
4
Takeover Bids
4
TFEU
4
Third-Party Relationships
4
Trademark Litigation
4
TRICARE
4
TTIP
4
UAW
4
Uber
4
Universities
4
Utility Patents
4
Value-Based Care
4
Viagra
4
Webinars
4
Whistleblower Protection Policies
4
Wire Fraud
3
Abuse of Discretion
3
Acquisition Agreements
3
Activist Investors
3
Advisory Opinions
3
Algorithmic Trading
3
Alibaba
3
Ambry
3
Amended Regulation
3
Amgen v Apotex
3
Animal Testing
3
Annual Reports
3
Anticompetitive Agreements
3
Ariosa
3
Asbestos
3
AZ Supreme Court
3
Bank of America
3
Benchmarks
3
Biometric Information
3
Bipartisan Agreement
3
Bitcoin
3
Brokers
3
Cadence Pharmaceuticals Inc.
3
Cadillac Tax
3
Cease and Desist Orders
3
Center for Drug Evaluation and Research (CDER)
3
Certificate of Need
3
CFPB
3
CFTC
3
Charles Grassley
3
Children's Products
3
Clear and Convincing Evidence
3
Collective Bargaining
3
Columbia
3
Comcast v. Behrend
3
Commerce Clause
3
Commercial General Liability Policies
3
Congressional Budget Office
3
Congressional Committees
3
Consent
3
Consumer Product Safety Commission (CPSC)
3
Consumer Protection Act
3
Contraceptive Coverage Mandate
3
Contract Disputes
3
Contract Negotiations
3
Conversion
3
Corporate Crimes